Tag Archives: Bronchospasm

FDA Approves First Generic of Proventil HFA Metered Dose Inhaler to Treat and Prevent Bronchospasm

April 08, 2020 — The U.S. Food and Drug Administration today approved the first generic of Proventil HFA (albuterol sulfate) Metered Dose Inhaler, 90 mcg/Inhalation, for the treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in… Read More »